Clinical Trials in the UK

New Worldwide Study For Patients with BCC Now Open in the UK

A new worldwide study of an oral drug for patients with BCC that is either extensive or spreading (metastatic) is now open in the the UK.

Read more: New Worldwide Study For Patients with BCC Now Open in the UK

LDE225 Recruiting in the UK

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors is now recruiting patients in the UK.

 Originally produced by Professor P. A. Farndon, Clinical Geneticist, Jim Costello (deceased) and Margaret Costello.  We are reliant on a team of medical advisors for the clinical content of the website. We are grateful for their continuing support. 
Gorlin Syndrome Group is Registered Charity in the UK - No 1096361 
 
Gorlin Syndrome community on HealthUnlocked
website security